Queen's Award presentation

ORION Clinical Services receives Queen’s Award from HRH Duke of Kent 2003

SLOUGH, 10 November 2003: ORION Clinical Services has celebrated the formal presentation of The Queen’s Award for Enterprise 2003 in the International Trade category for services in support of drug development. The presentation was made at its new headquarters at 7 Bath Road, Slough, by HRH Duke of Kent in the presence of the Lord Lieutenant of Berkshire, the Mayor and Mayoress of Slough and the Chief Executive of Slough Borough Council and all of the UK ORION team.

Phillip Wroughton, Lord Lieutenant of Berkshire, said “Through this Award today, you gain further national and international recognition of the immense value of the services you provide to the pharmaceutical and biotechnology industries. As your brochure proudly states you have developed a reputation for reliability and this is amply proven by the increasing demand for your advice and services which overseas alone have trebled in the past 3 years with particular impact in Europe, North America and Japan. You have a very large number of worldwide clients who remain hugely grateful for your research and clinical trials, and today we give you our congratulations and thanks.”

"Queen’s Awards are not easily won – in all the Queen made 123 Awards this year from over 1,000 applications. There were 62 Awards for International Trade from a field of 362 entries of odds of 6:1 against – proof indeed of your tremendous achievement.”

Dr Alan Irvine, Chief Executive Officer of ORION Clinical Services, said “Unlike a pharmaceutical company, we do not manufacture and sell medicinal products, we offer our individual and collective expertise to our pharmaceutical and biotechnology clients. Being a service company, our reputation is dependent upon the collective contributions of all staff involved on a project. This award has thus been earned by all present today, but also by many more ORION employees worldwide.”

Dr Fabrice Chartier, Chief Scientific Officer, said “The receipt of the Queen’s Award represents a tremendous step in our exceptional history. It truly reflects our international strategy, further strengthening our position to win and efficiently manage global clinical development projects.”

ORION Clinical Services is a full-service clinical development organisation performing all aspects of clinical trials internationally. The company is a dynamic, proactive multicultural CRO, offering a high quality, customised and flexible service. Clients include multinational organisations from Europe, North America and Japan as well as companies from the biotechnology sector. The company has experience of pharmaceutical and biotechnology products (including gene therapy) and of medical devices. ORION’s European operations are managed from offices in the United Kingdom and France, while North America is managed from the USA, and Australasia from Australia.